REQUEST A DEMO
Total
USD $0.00
Search more companies

Fizjo-Amicus Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Fizjo-Amicus Sp. z o.o. Profile Updated: April 18, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Fizjo-Amicus Sp. z o.o. is a company based in Poland, with its head office in Poznan. The company operates in the Pharmacies and Drug Stores industry. It was first established on January 31, 2018. The latest financial highlights indicate a net sales revenue increase of 46.55% in 2022. There was a total growth of 16.74% in Fizjo-Amicus Sp. z o.o.’s total assets over the same period. In, 2022, the company’s net profit margin decreased by 8.05%.

Headquarters
Ul. Slowianska 38B
Poznan; Wielkopolskie; Postal Code: 61-664

Contact Details: Purchase the Fizjo-Amicus Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Fizjo-Amicus Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Fizjo-Amicus Sp. z o.o. report to view the information.
Incorporation Date:
January 31, 2018
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
95%
Company Performance
Financial values in the chart are available after Fizjo-Amicus Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
46.55%
Total operating revenue
41.66%
Operating profit (EBIT)
7.17%
Net Profit (Loss) for the Period
6.02%
Total assets
16.74%
Total equity
40.3%
Operating Profit Margin (ROS)
-8.51%
Net Profit Margin
-8.05%
Return on Equity (ROE)
-9.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?